Literature DB >> 17669410

Native C-reactive protein induces endothelial dysfunction in ApoE-/- mice: implications for iNOS and reactive oxygen species.

Susanne B Schwedler1, Peter J Kuhlencordt, P Padmapriya Ponnuswamy, Gencay Hatiboglu, Thomas Quaschning, Julian Widder, Christoph Wanner, Lawrence A Potempa, Jan Galle.   

Abstract

OBJECTIVE: In addition to being a risk marker for cardiovascular disease, recent data suggests that C-reactive protein (CRP) induces endothelial dysfunction and promotes oxidative stress. We evaluated the effects of two conformers of CRP (pentameric, or native [nCRP], versus monomeric, or modified [mCRP]) on vessel function and production of reactive oxygen species (ROS) in an in-vivo model of atherosclerosis. METHODS AND
RESULTS: Female ApoE(-/-) mice, fed a "western-type" diet, were treated with either human nCRP or mCRP (2.5mg/kg s.c., weekly) or saline for 8 weeks. Endothelium-dependent and endothelium-independent vascular functions were assessed in isolated aortic rings under isometric conditions. Production of ROS in aortic rings was measured by electron spin resonance (ESR). Endothelium-dependent relaxation was impaired in nCRP-treated but not in mCRP-treated ApoE(-/-) mice. This impairment was reversed by preincubation with an inhibitor of inducible nitric oxide synthase (iNOS). Endothelium-independent relaxation, and iNOS and endothelial NOS (eNOS) protein expressions were similar among all groups. ESR experiments revealed lesser amounts of superoxide in the nCRP group as compared to the saline group, which is consistent with an increased transformation of NO to peroxynitrite.
CONCLUSIONS: nCRP can facilitate cardiovascular disease through impairment of endothelium-dependent vasoreactivity, in a manner that involves increased iNOS activity and a potential for increased peroxynitrite formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17669410     DOI: 10.1016/j.atherosclerosis.2007.06.013

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  14 in total

1.  C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1.

Authors:  Keiji Tanigaki; Chieko Mineo; Ivan S Yuhanna; Ken L Chambliss; Michael J Quon; Ezio Bonvini; Philip W Shaul
Journal:  Circ Res       Date:  2009-05-07       Impact factor: 17.367

Review 2.  Fcγ receptors and ligands and cardiovascular disease.

Authors:  Keiji Tanigaki; Nathan Sundgren; Amit Khera; Wanpen Vongpatanasin; Chieko Mineo; Philip W Shaul
Journal:  Circ Res       Date:  2015-01-16       Impact factor: 17.367

3.  Adeno-associated virus-mediated human C-reactive protein gene delivery causes endothelial dysfunction and hypertension in rats.

Authors:  Hongjing Guan; Peihua Wang; Rutai Hui; Matthew L Edin; Darryl C Zeldin; Dao Wen Wang
Journal:  Clin Chem       Date:  2008-12-04       Impact factor: 8.327

4.  C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction.

Authors:  Sridevi Devaraj; Jung-Mi Yun; Grete Adamson; Jose Galvez; Ishwarlal Jialal
Journal:  Cardiovasc Res       Date:  2009-07-20       Impact factor: 10.787

Review 5.  The evolving role of C-reactive protein in atherothrombosis.

Authors:  Sridevi Devaraj; Uma Singh; Ishwarlal Jialal
Journal:  Clin Chem       Date:  2008-12-18       Impact factor: 8.327

6.  Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance.

Authors:  Ishwarlal Jialal; Subodh Verma; Sridevi Devaraj
Journal:  Clin Chem       Date:  2008-12-18       Impact factor: 8.327

7.  C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells.

Authors:  Xinwen Wang; Dan Liao; Uddalak Bharadwaj; Min Li; Qizhi Yao; Changyi Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-12-20       Impact factor: 8.311

8.  Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo.

Authors:  Travis W Hein; Uma Singh; Jeannette Vasquez-Vivar; Sridevi Devaraj; Lih Kuo; Ishwarlal Jialal
Journal:  Atherosclerosis       Date:  2009-02-12       Impact factor: 5.162

9.  Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention.

Authors:  Yuan Hui Liu; Yong Liu; Ning Tan; Ji-Yan Chen; Jin Chen; Shao-Hui Chen; Yi-Ting He; Peng Ran; Piao Ye; Yun Li
Journal:  Int Urol Nephrol       Date:  2013-11-22       Impact factor: 2.370

Review 10.  CRP and the risk of atherosclerotic events.

Authors:  Paolo Calabrò; Enrica Golia; Edward T H Yeh
Journal:  Semin Immunopathol       Date:  2009-05-05       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.